Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes

(2013) Sheldon Greenfield   ANNALS OF INTERNAL MEDICINE

What Makes a Good Predictor?

(2010) John P. A. Ioannidis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heterogeneity Is Not Always Noise

(2009) Frank Davidoff   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score

(2009) Ioanna Tzoulaki   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Optimal Management of Acute Coronary Syndromes

(2009) L. David Hillis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early versus Delayed Invasive Intervention in Acute Coronary Syndromes

(2009) Shamir R. Mehta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dealing with heterogeneity of treatment effects: is the literature up to the challenge?

(2009) Nicole B Gabler et al.   Trials

A Percutaneous Coronary Intervention–Thrombolytic Predictive Instrument to Assist Choosing Between Immediate Thrombolytic Therapy Versus Delayed Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

(2008) David M. Kent et al.   AMERICAN JOURNAL OF CARDIOLOGY

Beyond the Randomized Clinical Trial

(2008) Brahmajee K. Nallamothu et al.   CIRCULATION

More on Subgroup Analyses in Clinical Trials

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Competing risk and heterogeneity of treatment effect in clinical trials

(2008) David M Kent et al.   Trials